{ "_description": "치료 타이밍 모델의 계층적 베이즈 UQ: class별 모집단 (lag,tau) 사후분포, 시험 간 분산, 식별성, 사후예측 밴드, LOTO 커버리지(mean-only vs population).", "model": "y_ij ~ N(A_i·(1-exp(-(t-lag_i)/tau_i)), sigma); lag_i~N(mu_lag,sd_lag), tau_i~N(mu_tau,sd_tau).", "classes": { "JAK_inhibitor": { "class": "JAK_inhibitor", "n_trajectories": 5, "trajectory_ids": [ "deuruxolitinib_THRIVE-AA1_12mg", "deuruxolitinib_THRIVE-AA1_8mg", "deuruxolitinib_THRIVE-AA2_12mg", "brepocitinib_NCT02974868", "ritlecitinib_NCT02974868" ], "lag_mean": 0.742, "lag_sd": 0.075, "lag_hdi90": [ 0.635, 0.837 ], "between_trial_lag_sd": 0.112, "tau_mean": 2.99, "tau_sd": 0.949, "tau_hdi90": [ 1.492, 4.483 ], "between_trial_tau_sd": 1.958, "sigma_mean": 0.027, "mulag_mutau_corr": -0.076, "prior_lag": 1.5, "prior_tau": 4.0, "post_band": { "months": [ 0, 0.5, 1, 1.5, 2, 3, 4, 6, 9, 12, 18, 24 ], "median": [ 0.0, 0.0, 0.0831, 0.2248, 0.3458, 0.5334, 0.6666, 0.8297, 0.938, 0.9774, 0.997, 0.9996 ], "lo": [ -0.045, -0.0438, -0.0003, 0.0853, 0.157, 0.2777, 0.3782, 0.5452, 0.7065, 0.8091, 0.9117, 0.9408 ], "hi": [ 0.045, 0.0508, 0.9136, 0.9935, 0.9974, 1.0046, 1.0096, 1.0166, 1.0251, 1.0321, 1.0387, 1.0418 ] }, "loto_coverage": { "nominal": 0.9, "mean_only_empirical": 0.531, "population_empirical": 1.0, "n_points": 32, "by_trajectory": [ { "held": "deuruxolitinib_THRIVE-AA1_12mg", "n": 6, "mean_in": 5, "pop_in": 6 }, { "held": "deuruxolitinib_THRIVE-AA1_8mg", "n": 6, "mean_in": 5, "pop_in": 6 }, { "held": "deuruxolitinib_THRIVE-AA2_12mg", "n": 6, "mean_in": 5, "pop_in": 6 }, { "held": "brepocitinib_NCT02974868", "n": 7, "mean_in": 1, "pop_in": 7 }, { "held": "ritlecitinib_NCT02974868", "n": 7, "mean_in": 1, "pop_in": 7 } ] } }, "finasteride": { "class": "finasteride", "n_trajectories": 3, "trajectory_ids": [ "finasteride_1mg_NCT01231607", "finasteride_1mg_Kaufman_2yr", "finasteride_oral_P3074_NCT03004469" ], "lag_mean": 0.943, "lag_sd": 0.642, "lag_hdi90": [ 0.086, 1.863 ], "between_trial_lag_sd": 0.514, "tau_mean": 2.99, "tau_sd": 2.237, "tau_hdi90": [ 0.109, 6.064 ], "between_trial_tau_sd": 3.3, "sigma_mean": 0.046, "mulag_mutau_corr": -0.118, "prior_lag": 3.0, "prior_tau": 6.0, "post_band": { "months": [ 0, 0.5, 1, 1.5, 2, 3, 4, 6, 9, 12, 18, 24 ], "median": [ 0.0, 0.0, 0.0618, 0.2069, 0.3287, 0.5361, 0.6798, 0.8493, 0.9533, 0.9851, 0.9985, 0.9998 ], "lo": [ -0.0838, -0.0717, -0.0517, -0.0311, -0.009, 0.0843, 0.198, 0.3546, 0.5146, 0.6342, 0.7739, 0.8467 ], "hi": [ 0.085, 0.7056, 0.9896, 1.012, 1.0258, 1.0432, 1.0498, 1.0602, 1.0661, 1.071, 1.0768, 1.0794 ] }, "loto_coverage": { "nominal": 0.9, "mean_only_empirical": 0.778, "population_empirical": 0.889, "n_points": 9, "by_trajectory": [ { "held": "finasteride_1mg_NCT01231607", "n": 3, "mean_in": 3, "pop_in": 3 }, { "held": "finasteride_1mg_Kaufman_2yr", "n": 3, "mean_in": 2, "pop_in": 2 }, { "held": "finasteride_oral_P3074_NCT03004469", "n": 3, "mean_in": 2, "pop_in": 3 } ] } }, "dutasteride": { "class": "dutasteride", "n_trajectories": 2, "trajectory_ids": [ "dutasteride_0.5mg_NCT01231607", "dutasteride_0.5mg_NCT00441116" ], "lag_mean": 1.096, "lag_sd": 0.447, "lag_hdi90": [ 0.311, 1.679 ], "between_trial_lag_sd": 0.585, "tau_mean": 2.289, "tau_sd": 1.524, "tau_hdi90": [ 0.1, 4.196 ], "between_trial_tau_sd": 2.374, "sigma_mean": 0.0, "mulag_mutau_corr": -0.012, "prior_lag": 2.5, "prior_tau": 5.0, "post_band": { "months": [ 0, 0.5, 1, 1.5, 2, 3, 4, 6, 9, 12, 18, 24 ], "median": [ 0.0, 0.0, 0.0, 0.1809, 0.356, 0.6106, 0.7653, 0.9161, 0.9818, 0.9961, 0.9998, 1.0 ], "lo": [ -0.0, -0.0, -0.0, -0.0, 0.0, 0.1394, 0.2673, 0.4566, 0.6427, 0.7483, 0.895, 0.9481 ], "hi": [ 0.0, 0.284, 0.9498, 0.9995, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0 ] }, "loto_coverage": null } }, "overall_coverage": { "nominal": 0.9, "mean_only_empirical": 0.585, "population_empirical": 0.976, "n_points": 41 } }